MedComms Experts (“MCE” or the “Company”), a global provider of rare-disease-focused medical communications services, is pleased to announce a strategic investment by The Brydon Group (“Brydon”). MCE bridges the gap between its global base of biopharma clients and healthcare professionals (“HCPs”) via high-science content and effective communication strategies that facilitate understanding of rare disease therapies. The Company offers a unique blend of scientific accuracy, creativity, and innovation. As part of the investment, Brydon will make significant investments into furthering MCE’s services, and into new technologies that will allow MCE to stay at the forefront of scientific creativity.
Read the full article: MedComms Experts Announces Strategic Investment by The Brydon Group //
Source: https://www.prnewswire.com/news-releases/medcomms-experts-announces-strategic-investment-by-the-brydon-group-302388027.html